Table 4. Nonroutine Encounters in the Medical Center.
Infant No.a | DOL | Setting | Chief complaint | Admitted | Outcome | SARS-CoV-2 retesting | SARS-CoV-2 test result |
---|---|---|---|---|---|---|---|
1b | 25 | ED to hospital | Fever | Yes | ROS negative, antibiotics | Yes | Not detected |
2b | 23 | Telehealth | Rash | No | Presciption for nystatin | No | NA |
3b | 13 | ED | Loud crying | No | Anticipatory guidance given | No | NA |
3b | 23 | Telehealth | ED follow-up | No | Anticipatory guidance given | No | NA |
4b | 18 | ED | Choking/respiratory distress | No | Anticipatory guidance given | No | NA |
4b | 20 | Telehealth | ED follow-up | No | No more choking | No | NA |
5 | 3 | Hospital | Hyperbilirubinemia | Yes | Phototherapy | Yes | Not detected |
6 | 12 | Telehealth | Constipation | No | Anticipatory guidance given | No | NA |
7 | 4 | ED | Congestion, belly breathing | No | Anticipatory guidance given | No | NA |
7 | 9 | Telehealth | Breastfeeding concern | No | Breastfeeding counseling | No | NA |
8 | 14 | Telehealth | Fussiness | No | Anticipatory guidance given | No | NA |
8 | 19 | Clinic | Abnormal NBS result | No | Laboratory draw for repeated TFTs | No | NA |
9 | 7 | Telehealth | Breastfeeding concern | No | Breastfeeding counseling | No | NA |
10 | 13 | Telehealth | Breastfeeding concern | No | Breastfeeding counseling | No | NA |
11 | 14 | Telehealth | Constipation | No | Anticipatory guidance given | No | NA |
11 | 18 | ED to hospital | Fever | Yes | Antibiotics, negative ROS workup findings | Yes | Not detected |
12 | 12 | Telehealth | Umbilical drainage | No | Anticipatory guidance given | No | NA |
12 | 15 | Telehealth | Umbilical drainage | No | Anticipatory guidance given | No | NA |
13 | 6 | Hospital | Fever | Yes | Positive ROS finding, UTI, antibiotics | Yes | Not detected |
13 | 10 | COVID-19 clinic | Weight loss | No | Minimal weight gain | No | NA |
13 | 15 | COVID-19 clinic | Weight loss | No | Gaining weight | No | NA |
14 | 9 | Feeding concerns | No | Anticipatory guidance given | No | NA | |
15 | 9 | Telehealth | Excessive stool | No | Anticipatory guidance given | No | NA |
16 | 7 | Telehealth | Bloody vaginal discharge | No | Anticipatory guidance given | No | NA |
17 | 7 | Telehealth | Breastfeeding concern | No | Breastfeeding counseling | No | NA |
18 | 11 | COVID-19 clinic | Weight loss | No | Gaining weight | Yes | Not detected |
18 | 12 | Telehealth | Fussiness, spit up | No | Anticipatory guidance given | No | NA |
19 | 10 | Telehealth | Breastfeeding concern, infant sleep | No | Breastfeeding counseling, anticipatory guidance given | No | NA |
20 | 10 | Telehealth | Breastfeeding concern | No | Breastfeeding counseling | No | NA |
21 | 5 | COVID-19 clinic | Weight loss | No | Gaining weight | No | NA |
22 | 6 | ED | Repeated bilirubin level measurement | No | Bilirubin level decreased | No | NA |
23 | 3 | ED | Hyperbilirubinemia | No | Phototherapy | Yes | Not detected |
Abbreviations: COVID-19, coronavirus disease 2019; DOL, days of life; ED, emergency department; NA, not applicable; NBS, newborn screening; ROS, rule-out sepsis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TFTs, thyroid function tests; UTI, urinary tract infection.
Numbering refers to the order in which these 22 infants had encounters identified in our electronic medical record and is not reflective of newborn order in the cohort.
Newborn was previously described.